Semaglutide Cost Per Month — Complete Pricing Guide

The most searched questions about semaglutide pricing all share the same frustration: the price you see advertised is almost never the price you actually pay. That can work in your favor — or badly against you — depending on your insurance and how you access the drug. Every major question is answered plainly below.

• 1
  How much does semaglutide cost per month without insurance? Brand-name list price: $998–$1,349/month · NovoCare direct cash-pay: $199/month (starter doses) then $349/month · New Wegovy pill: $149/month for starter doses · Big-picture: most patients don’t pay list price

  The list price of brand-name semaglutide medications — what the drug costs before any discount or insurance — runs $998–$1,349 per month depending on the specific product and dose. Ozempic lists around $1,027 per fill; Wegovy injection around $1,349. But Novo Nordisk now runs a direct-to-patient pharmacy program through NovoCare that dramatically undercuts those numbers for uninsured or self-paying patients. As of mid-2026, new patients can get Wegovy or Ozempic starter doses (0.25 mg and 0.5 mg) for $199/month for the first two months through NovoCare, then $349/month for standard doses going forward. The newly FDA-approved Wegovy pill (approved December 2025) is available through NovoCare at $149/month for starter doses and $299/month for higher doses. These prices are real and current — they’re Novo Nordisk’s response to both political pressure and competition from compounded versions. Go directly to novocare.com to confirm eligibility and access.
• 2
  How do I get semaglutide for $25 a month? The $25/month Ozempic price requires: commercial (private) insurance that covers Ozempic + the Novo Nordisk savings card · NOT available with Medicare or Medicaid · Maximum savings: $100/month cap · Good for up to 48 months

  The $25/month Ozempic price is real — but it comes with conditions that disqualify many people who search for it. To pay $25/month, you must have commercial (private employer or marketplace) insurance that covers Ozempic for type 2 diabetes, and you must use the Novo Nordisk Ozempic Savings Offer card at the pharmacy. The savings card covers the gap between your insurance copay and $25, up to a maximum of $100 per month in savings. It is valid for up to 48 months. What it is not: it is not available to patients on Medicare, Medicaid, or any other government-funded insurance — federal anti-kickback rules prohibit manufacturer savings cards from applying to government insurance programs. If you have Medicare or Medicaid, you need a different strategy (covered below). To check eligibility and get the card: novocare.com or ask your pharmacist.
• 3
  What is the Wegovy price per month? List price: ~$1,349/month · NovoCare cash-pay injection: $199 (starter doses) → $349/month · NovoCare Wegovy pill: $149 (starter doses) → $299/month · With commercial insurance + savings card: as low as $0/month · Medicare (cardiovascular indication): covered under Part D, subject to $2,000/yr OOP cap

  Wegovy is the FDA-approved semaglutide product specifically indicated for weight loss and, since 2024, for reducing cardiovascular risk in adults with obesity or overweight and established heart disease. As of late 2025, it is now available in both injectable and pill forms — the oral Wegovy pill was FDA-approved in December 2025 and became available in over 70,000 pharmacies starting January 2026. The pill is a significant convenience development because it eliminates weekly injections, which some people find difficult or uncomfortable. For patients with commercial insurance whose plan covers Wegovy, a savings card can reduce cost to $0/month. For self-pay patients without insurance, NovoCare Pharmacy’s cash-pay program brings the injection to $349/month and the pill to $299/month for most doses. One important and recent development: Novo Nordisk announced in February 2026 that the list price for Wegovy will drop approximately 50% — to $675/month — effective January 2027. That is still high, but it’s a meaningful shift for how insurance companies and PBMs negotiate coverage.
• 4
  Does Medicare cover Ozempic or Wegovy? Ozempic for type 2 diabetes: YES — Medicare Part D covers it · Ozempic for weight loss only: NO · Wegovy for cardiovascular risk reduction (in patients with heart disease + obesity): YES, since 2024 · Wegovy for weight loss only (no heart disease): Starting July 2026 via Medicare GLP-1 Bridge · Manufacturer savings cards: NOT usable with Medicare

  Medicare’s coverage of semaglutide has been one of the most rapidly changing areas in drug policy, and what’s true today was not true two years ago. Here is the current breakdown. Medicare Part D has always covered Ozempic when prescribed specifically for type 2 diabetes — roughly 94% of Part D plans include it on their formularies. What Medicare did not cover was semaglutide prescribed purely for weight loss — a prohibition dating to the 2003 law that created Medicare Part D. That restriction is being lifted in stages. First, following the FDA’s 2024 approval of Wegovy to reduce cardiovascular events, Medicare began covering it for patients who have documented heart disease and are overweight or obese. Starting July 2026, the Medicare GLP-1 Bridge program is expected to expand coverage of Wegovy and Zepbound for weight loss to eligible beneficiaries with BMI of 35+, or BMI of 27+ with conditions like pre-diabetes, hypertension, or cardiovascular disease, at a copay around $50/month. The 2025 Inflation Reduction Act’s $2,000 annual Part D out-of-pocket cap also means many Medicare patients who do qualify hit their limit within a few months and pay $0 for the rest of the year. Important: manufacturer savings cards like the $25 Ozempic card do not work with Medicare due to federal rules. Do not waste time trying to use them if you’re on Medicare.
• 5
  What happened to compounded semaglutide — is it still available? Compounded semaglutide injections: FDA declared shortage over Feb 2025 — large-scale compounding now prohibited · Some 503A telehealth pharmacies still offer patient-specific compounded versions legally · Hims & Hers compounded pill ($49/mo): Novo Nordisk sued in Feb 2026, FDA warned · The regulatory environment is actively tightening

  Compounded semaglutide was widely available from 2022 through early 2025 because FDA rules allow compounding of drugs during official shortages. Telehealth companies like Hims & Hers, Ro, and others were selling compounded injectable semaglutide for $100–$300/month — far below brand-name prices — and millions of patients used it. In February 2025, the FDA declared the semaglutide injection shortage resolved, triggering a legal requirement to phase out large-scale compounding. The FDA set deadlines: state-licensed 503A pharmacies had until April 22, 2025; FDA-licensed 503B outsourcing facilities until May 22, 2025. Despite this, some telehealth platforms continued compounding under arguments about “personalized doses.” In September 2025, the FDA issued over 55 warning letters. In February 2026, Novo Nordisk sued Hims & Hers directly over its $49/month compounded semaglutide pill. On April 30, 2026, the FDA proposed removing semaglutide and tirzepatide from the 503B bulk compounding list entirely and opened a public comment period through June 29, 2026. This is a proposal, not yet a final rule — some 503A telehealth pharmacies can still legally compound with valid patient-specific prescriptions. But the window is actively closing, and patients relying on compounded versions for their affordability are in an increasingly uncertain position.
• 6
  What is the cost of Ozempic at Walmart, Costco, or other pharmacies? Ozempic without insurance varies by pharmacy · GoodRx coupon at most chains: ~$149–$250/month · No pharmacy sells Ozempic below list without a discount card or insurance · Walmart and Costco do not manufacture semaglutide — they fill the same brand-name prescription · Always use a GoodRx coupon or the NovoCare savings card for best cash price

  Walmart, Costco, CVS, Walgreens, Kroger, and other pharmacies all dispense brand-name Ozempic and Wegovy — but they fill the same FDA-approved Novo Nordisk product at prices that are set by their pharmacy benefit managers and supplier contracts. None of these retailers can produce or sell cheaper versions of semaglutide themselves. What varies is the retail cash price and what coupons they accept. A GoodRx coupon reduces the cash price of the most common Ozempic pen at most major chains to roughly $149–$250/month — a steep discount from the $1,000+ list price but still meaningful out-of-pocket. Costco’s pharmacy tends to have slightly lower retail drug prices than chain pharmacies and accepts GoodRx coupons. Walmart’s ReliOn Health brand does manufacture affordable insulin (a different drug entirely), but no comparable low-cost semaglutide alternative exists from any mass retailer. For the absolute lowest verified cash price, compare GoodRx, RxSaver, and NovoCare’s direct pharmacy prices side by side — they differ enough to matter. Never pay full retail price for semaglutide at any pharmacy without checking these.
• 7
  Can you lose weight on semaglutide 2.4 mg — how much and how fast? Average weight loss at 2.4 mg: 15–17% of body weight over 68 weeks in clinical trials · Real-world data: 13.4% at 6 months, 17.6% at 12 months, 20.3% at 18 months · About 1/3 of patients lose 20%+ · New 7.2 mg dose (FDA-approved March 2026): average 20.7% weight loss

  The clinical evidence on semaglutide’s weight loss effectiveness is among the strongest ever published for an obesity medication. In the pivotal STEP 1 trial, participants taking 2.4 mg weekly Wegovy lost an average of about 15% of their starting body weight over 68 weeks — meaning someone starting at 220 pounds would lose roughly 33 pounds. A 2025 real-world study of 8,177 patients found even slightly better results in practice: 13.4% average loss at 6 months, 17.6% at 12 months, and 20.3% at 18 months when people stayed on the medication. About one third of all patients in clinical trials lost 20% or more of their starting weight. The FDA-approved Wegovy HD (7.2 mg dose, approved March 2026) showed even greater results in the STEP UP trial — average weight loss of 20.7% at 72 weeks, with roughly a third of patients losing 25% or more. There are two critical limitations to understand: weight loss continues only as long as you take the medication, and most studies show significant weight regain within one to two years of stopping. This is not a one-course treatment for most patients — it’s a chronic medication for a chronic condition, similar to blood pressure medication.
• 8
  What is the strongest weight loss prescription pill with semaglutide? Wegovy oral tablet 25 mg (FDA-approved December 2025): ~14–17% average weight loss in OASIS 4 trial · Available at pharmacies since January 2026 · Cash-pay: $149–$299/month through NovoCare · Currently the highest-dose FDA-approved oral semaglutide for weight loss

  The oral Wegovy pill — semaglutide 25 mg once daily — became the first FDA-approved oral GLP-1 medicine specifically for obesity when it was cleared in December 2025. It arrived at pharmacies in January 2026 and drew over 170,000 patients in its first four weeks. The approval was based on the OASIS 4 phase 3 trial, which showed average weight loss of roughly 17% for patients who completed the full treatment protocol, and 14% when accounting for all enrolled patients regardless of whether they stayed on therapy. The pill is taken once daily in the morning at least 30 minutes before eating, with no more than 4 oz of water — a specific requirement that affects absorption. It reaches therapeutic levels more slowly than the injection, which is why results in the pill trials are slightly lower than the injectable 2.4 mg formulation. NovoCare Pharmacy currently offers it at $149/month for 1.5 mg starter doses and $299/month for the 7 mg and higher doses. For patients who dislike needles or can’t tolerate injections, this oral option is a meaningful development — and Novo Nordisk clearly intended it as a direct counter to Hims & Hers’ compounded semaglutide pill, priced at less than a third of what compounders were charging.

The same drug. Very different prices. Your actual monthly cost depends entirely on which version, which access pathway, and what your insurance covers. Use this table to find your scenario.

Use the buttons below to find endocrinologists, weight management clinics, pharmacies that carry semaglutide, and telehealth services near you. Always work with a licensed prescriber before starting or changing semaglutide therapy.